Metacare Co., Ltd. (118000.KS) Financial Statements

Income statement

Metric	TTM	2025	2024	2023	2022
Revenue
Total Revenue	39.9B	32.8B	20.2B	17.3B	19.1B
Cost of Revenue	31.6B	25.4B	12.5B	10.7B	12.6B
Gross Profit	8.4B	7.5B	7.7B	6.5B	6.5B
Operating Expenses
R&D Expense	—	—	—	1.2B	2.2B
SG&A Expense	3.2B	1.9B	1.4B	1.4B	1.9B
General & Admin Expense	315.5M	323.1M	108.2M	62.2M	98.1M
Selling & Marketing Expense	1.5B	1.5B	1.3B	1.3B	1.8B
Other Expenses	5.1B	4.3B	4.8B	3.0B	2.6B
Total Operating Expenses	7.8B	6.1B	6.2B	5.6B	6.8B
Cost and Expenses	38.6B	31.5B	18.7B	16.3B	19.3B
Operating Income (EBIT)	1.3B	1.3B	1.5B	1.0B	(300.5M)
Non-Operating
Interest Income	98.8M	207.2M	1.0B	1.2B	1.8B
Interest Expense	2.8B	2.4B	399.3M	3.3B	5.5B
Net Interest Income	(2.7B)	(2.2B)	640.8M	(2.1B)	(3.8B)
Other Non-Op Income/Expense	(2.9B)	(1.5B)	1.2B	(5.5B)	(49.3B)
Non-Operating Income (excl Interest)	1.8B	—	(1.6B)	2.0B	43.8B
EBT (Pre-Tax Income)	(1.6B)	(204.9M)	2.7B	(4.5B)	(49.6B)
Income Tax Expense	(69.9M)	7.0M	—	3.7M	32.7B
Bottom Line
Net Income	(2.0B)	498.2M	9.3B	(14.5B)	(49.6B)
Earnings from Cont. Ops	(1.5B)	(211.9M)	2.7B	(4.5B)	(49.6B)
Earnings from Discont. Ops	—	—	5.7B	(21.5B)	—
Bottom Line Net Income	(2.2B)	498.2M	9.3B	(14.5B)	(49.6B)
Per Share
Basic EPS	(₩121)	₩30	₩613	(₩1,380)	(₩5,905)
Diluted EPS	(₩121)	₩30	₩613	(₩1,378)	(₩5,905)
Revenue Per Share	₩2,242	₩1,911	₩1,336	₩1,638	₩2,276
Shares
Basic Shares Outstanding	17.8M	17.2M	15.1M	10.5M	8.4M
Diluted Shares Outstanding	17.8M	17.2M	15.1M	10.6M	8.4M
Profitability Metrics
EBITDA	4.3B	4.6B	6.1B	3.2B	(27.7B)
D&A	3.0B	3.3B	3.0B	4.7B	2.0B
EBIT	1.3B	1.3B	3.1B	1.0B	(29.6B)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026